Notice of updates

We’ve updated our Financial Services Guide (FSG), effective 18 November 2025. By continuing to use our services after this date, you accept the revised terms.

Read FSG

icon
HALO logo
halo search icon
Alnylam Pharmaceuticals, Inc

US$318.85

Price Change Indicator
-9.88 (-3.006%)
Alnylam Pharmaceuticals, Inc
ALNY · NAS

Alnylam Pharmaceuticals, Inc

Start Trading ALNY for Free

US$318.85

Price Arrow-9.88 (-3.006%)
02/04/2026 04:00:00 PM
All-CompaniesAll-ConsensusConsensus CheapHALO 500HALO AllHALO Balance SheetHALO Capital EfficiencyHALO Price Momentum+1
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Alnylam Pharmaceuticals, Inc Overview

ALNY Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Neutral

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Strong

Earnings

Very Weak

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About ALNY

icon
icon

Telephone

1.617.551.8200

icon

Address

Henri A. Termeer Square, 675 West Kendall Street, Cambridge, MA 02142

Description

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002, and is headquartered in Cambridge, MA.

ALNY Price Chart

Key Stats

Market Cap

US$42.29B

PE

130.80

EV/EBITDA

58.8

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 205.87 - 495.55

Trade Value (12mth)

US$111,038,929.00

1 week

0.47%

1 month

-2.58%

YTD

-20.32%

1 year

35.25%

All time high

495.55

Key Fundamentals

EPS 3 yr Growth

-125.10%

EBITDA Margin

0.00%

Operating Cashflow

$498m

Free Cash Flow Return

0.00%

ROIC

0.00%

Interest Coverage

0.00

Quick Ratio

0.00

Other Data

Shares Outstanding (Fully Diluted)

131m

HALO Sector

Healthcare

Next Company Report Date

18-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

ALNY Announcements

Latest Announcements

DateAnnouncements
05 March 26
05 March 26
13 February 26
13 February 26
13 February 26

ALNY Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-3.52-2.182.33locklocklock
EPS (Fully Diluted)
 $locklocklocklock-3.52-2.18N/Alocklocklock
Growth
 %locklocklocklock62.138.2206.9locklocklock
PE
 XlocklocklocklockN/AN/A130.8locklocklock
EV/EBITDA
 XlocklocklocklockN/AN/A58.8locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Alnylam Pharmaceuticals, Inc (ALNY:NAS)?
Halo FAQ
The current share price of Alnylam Pharmaceuticals, Inc (ALNY:NAS) is USD$318.85.
What is the 52-week high share price for Alnylam Pharmaceuticals, Inc (ALNY:NAS)?
Halo FAQ
The 52-week high share price for Alnylam Pharmaceuticals, Inc (ALNY:NAS) is USD$495.55.
What is the 52-week low share price for Alnylam Pharmaceuticals, Inc (ALNY:NAS)?
Halo FAQ
The 52-week low share price for Alnylam Pharmaceuticals, Inc (ALNY:NAS) is USD$205.87.
What is the dividend yield for Alnylam Pharmaceuticals, Inc (ALNY:NAS)?
Halo FAQ
Alnylam Pharmaceuticals, Inc (ALNY:NAS) does not pay a dividend.
What was Alnylam Pharmaceuticals, Inc (ALNY:NAS) last dividend payment?
Halo FAQ
Alnylam Pharmaceuticals, Inc (ALNY:NAS) does not pay a dividend.
What is the franking level for Alnylam Pharmaceuticals, Inc (ALNY:NAS)?
Halo FAQ
Alnylam Pharmaceuticals, Inc (ALNY:NAS) has a franking level of 0.00%.
In which sector is Alnylam Pharmaceuticals, Inc (ALNY:NAS) classified?
Halo FAQ
Alnylam Pharmaceuticals, Inc (ALNY:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Alnylam Pharmaceuticals, Inc (ALNY:NAS)?
Halo FAQ
The current P/E ratio for Alnylam Pharmaceuticals, Inc (ALNY:NAS) is 130.80.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial